117 related articles for article (PubMed ID: 19621750)
1. [Investigations of fibrin clots formation under the effect of thrombin and ancystron].
Savchuk OM; Chernyshov VI; Volkov HL
Ukr Biokhim Zh (1999); 2004; 76(3):122-5. PubMed ID: 19621750
[TBL] [Abstract][Full Text] [Related]
2. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
[TBL] [Abstract][Full Text] [Related]
3. Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity.
Seeger W; Elssner A; Günther A; Krämer HJ; Kalinowski HO
Am J Respir Cell Mol Biol; 1993 Aug; 9(2):213-20. PubMed ID: 8338688
[TBL] [Abstract][Full Text] [Related]
4. Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers.
Langer BG; Weisel JW; Dinauer PA; Nagaswami C; Bell WR
J Biol Chem; 1988 Oct; 263(29):15056-63. PubMed ID: 3170575
[TBL] [Abstract][Full Text] [Related]
5. The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure.
Ho W; Tawil B; Dunn JC; Wu BM
Tissue Eng; 2006 Jun; 12(6):1587-95. PubMed ID: 16846354
[TBL] [Abstract][Full Text] [Related]
6. Changes in adsorbed fibrinogen upon conversion to fibrin.
Evans-Nguyen KM; Fuierer RR; Fitchett BD; Tolles LR; Conboy JC; Schoenfisch MH
Langmuir; 2006 May; 22(11):5115-21. PubMed ID: 16700602
[TBL] [Abstract][Full Text] [Related]
7. Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties.
Helms CC; Kapadia S; Gilmore AC; Lu Z; Basu S; Kim-Shapiro DB
Blood Coagul Fibrinolysis; 2017 Jul; 28(5):356-364. PubMed ID: 27755019
[TBL] [Abstract][Full Text] [Related]
8. [Interaction of a peptide inhibitor with two forms of monomeric fibrin differing in the degree of activation].
Chiriat'ev EA; Leonova OP; Byshevskiĭ ASh
Ukr Biokhim Zh (1978); 1989; 61(1):3-9. PubMed ID: 2741239
[TBL] [Abstract][Full Text] [Related]
9. Release of fibrinopeptides by the slow and fast forms of thrombin.
Vindigni A; Di Cera E
Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
[TBL] [Abstract][Full Text] [Related]
10. The isolation of fibrinogen monomer dramatically influences fibrin polymerization.
Huang L; Lord ST
Thromb Res; 2013 Jun; 131(6):e258-63. PubMed ID: 23622556
[TBL] [Abstract][Full Text] [Related]
11. Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface.
Campbell RA; Overmyer KA; Bagnell CR; Wolberg AS
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2247-54. PubMed ID: 18974382
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of soluble fibrin in plasma by affinity chromatography--a comparative study with desAA-fibrin, desAABB-fibrin and fibrinogen.
Thiel W; Delvos U; Müller-Berghaus G
Thromb Haemost; 1985 Aug; 54(2):533-8. PubMed ID: 4082091
[TBL] [Abstract][Full Text] [Related]
13. Coarse-grained molecular dynamics simulations of fibrin polymerization: effects of thrombin concentration on fibrin clot structure.
Yesudasan S; Wang X; Averett RD
J Mol Model; 2018 Apr; 24(5):109. PubMed ID: 29623504
[TBL] [Abstract][Full Text] [Related]
14. Effect of Lipid Surface Composition on the Formation and Structure of Fibrin Clots.
Bakirova DR; Faizullin DA; Valiullina YA; Salnikov VV; Zuev YF
Bull Exp Biol Med; 2017 Oct; 163(6):722-725. PubMed ID: 29063338
[TBL] [Abstract][Full Text] [Related]
15. Oxidative modification of fibrinogen inhibits its transformation into fibrin under the effect of thrombin.
Azizova OA; Piryazev AP; Aseychev AV; Shvachko AG
Bull Exp Biol Med; 2009 Feb; 147(2):201-3. PubMed ID: 19513421
[TBL] [Abstract][Full Text] [Related]
16. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.
Kumar R; Béguin S; Hemker HC
Thromb Haemost; 1995 Sep; 74(3):962-8. PubMed ID: 8571330
[TBL] [Abstract][Full Text] [Related]
17. Sensing adhesion forces between erythrocytes and γ' fibrinogen, modulating fibrin clot architecture and function.
Guedes AF; Carvalho FA; Domingues MM; Macrae FL; McPherson HR; Santos NC; Ariёns RAS
Nanomedicine; 2018 Apr; 14(3):909-918. PubMed ID: 29410160
[TBL] [Abstract][Full Text] [Related]
18. Controllable self-assembly from fibrinogen-gold (fibrinogen-Au) and thrombin-silver (thrombin-Ag) nanoparticle interaction.
Roy S; Dasgupta AK
FEBS Lett; 2007 Nov; 581(28):5533-42. PubMed ID: 17983601
[TBL] [Abstract][Full Text] [Related]
19. [Features of the structure of fibrin clots, connected with conditions of gel formation].
Savchuk AN; Makogonenko EM
Ukr Biokhim Zh (1999); 2001; 73(4):123-7. PubMed ID: 12035519
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate-binding activities of coagulation factors fibrinogen and fibrin.
Date K; Ohyama M; Ogawa H
Glycoconj J; 2015 Aug; 32(6):385-92. PubMed ID: 26050259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
